Magnesium Isoglycyrrhizinate
- Generic Name
- Magnesium Isoglycyrrhizinate
- Indication
用于慢性病毒性肝炎和急性药物性肝损伤，改善肝功能异常。
Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia
Not Applicable
Not yet recruiting
- Conditions
- Drug Induced Liver Injury
- Interventions
- Procedure: Plaslna exchangeProcedure: Liver transplantation
- First Posted Date
- 2025-04-10
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- General Hospital of Shenyang Military Region
- Target Recruit Count
- 232
- Registration Number
- NCT06922669
- Locations
- 🇨🇳
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang, Liaoning, China
Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B
Phase 4
- Conditions
- Chronic Hepatitis bLiver Inflammation
- Interventions
- Drug: Magnesium Isoglycyrrhizinate PlaceboDrug: Diammonium Glycyrrhizinate Placebo
- First Posted Date
- 2017-11-21
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- Cttq
- Target Recruit Count
- 480
- Registration Number
- NCT03349008
Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury
- First Posted Date
- 2013-03-04
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Cttq
- Target Recruit Count
- 2040
- Registration Number
- NCT01802996
- Locations
- 🇨🇳
The first hospital of Nanjing, Nanjing, Jiangsu, China
🇨🇳The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, Anhui, China
🇨🇳China PLA General Hospital, Beijing, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath